BRCA-2 (+) high-grade serous fallopian tube cancer diagnosed as an isolated breast mass by mammography

Ovarian cancer typically presents at advanced stage with intra-abdominal metastases. Rarely, ovarian cancer presents with distant metastases with little to no intra-abdominal disease burden. The patient was a BRCA-2 germline mutation carrier diagnosed with a Stage IVB high-grade carcinoma of the fal...

Full description

Bibliographic Details
Main Authors: Janelle N. Sobecki, Kathryn A. Dryer, Aparna M. Mahajan, Ryan J. Spencer
Format: Article
Language:English
Published: Elsevier 2021-02-01
Series:Gynecologic Oncology Reports
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2352578920301569
id doaj-a6489996b2344147ad2c56324ba323c1
record_format Article
spelling doaj-a6489996b2344147ad2c56324ba323c12021-02-11T04:21:45ZengElsevierGynecologic Oncology Reports2352-57892021-02-0135100690BRCA-2 (+) high-grade serous fallopian tube cancer diagnosed as an isolated breast mass by mammographyJanelle N. Sobecki0Kathryn A. Dryer1Aparna M. Mahajan2Ryan J. Spencer3Division of Gynecologic Oncology, University of Wisconsin-Madison School of Medicine and Public Health, United States; Corresponding author at: 600 Highland Ave. H4/676, Madison, WI 53792, United States.Department of Obstetrics & Gynecology, University of Wisconsin-Madison School of Medicine and Public Health, United StatesDepartment of Pathology and Laboratory Medicine, University of Wisconsin-Madison School of Medicine and Public Health, United StatesDivision of Gynecologic Oncology, University of Wisconsin-Madison School of Medicine and Public Health, United StatesOvarian cancer typically presents at advanced stage with intra-abdominal metastases. Rarely, ovarian cancer presents with distant metastases with little to no intra-abdominal disease burden. The patient was a BRCA-2 germline mutation carrier diagnosed with a Stage IVB high-grade carcinoma of the fallopian tube following discovery of a right axillary breast mass on screening mammography. Pre-operative imaging was without evidence of metastatic disease in the abdomen or pelvis. She underwent surgical staging followed by adjuvant chemotherapy and maintenance poly-ADP ribose polymerase (PARP) inhibition. She is without evidence of disease 24 months following her surgical staging procedure. An isolated oligo metastasis in the axilla is a rare presentation of ovarian carcinoma. Extra-abdominal metastases can present a diagnostic challenge in ovarian cancer necessitating thorough pathologic and radiologic work-up, particularly in the absence of intra-abdominal disease.http://www.sciencedirect.com/science/article/pii/S2352578920301569Ovarian cancer distant metastasisBRCA-2Breast massPARP inhibitor
collection DOAJ
language English
format Article
sources DOAJ
author Janelle N. Sobecki
Kathryn A. Dryer
Aparna M. Mahajan
Ryan J. Spencer
spellingShingle Janelle N. Sobecki
Kathryn A. Dryer
Aparna M. Mahajan
Ryan J. Spencer
BRCA-2 (+) high-grade serous fallopian tube cancer diagnosed as an isolated breast mass by mammography
Gynecologic Oncology Reports
Ovarian cancer distant metastasis
BRCA-2
Breast mass
PARP inhibitor
author_facet Janelle N. Sobecki
Kathryn A. Dryer
Aparna M. Mahajan
Ryan J. Spencer
author_sort Janelle N. Sobecki
title BRCA-2 (+) high-grade serous fallopian tube cancer diagnosed as an isolated breast mass by mammography
title_short BRCA-2 (+) high-grade serous fallopian tube cancer diagnosed as an isolated breast mass by mammography
title_full BRCA-2 (+) high-grade serous fallopian tube cancer diagnosed as an isolated breast mass by mammography
title_fullStr BRCA-2 (+) high-grade serous fallopian tube cancer diagnosed as an isolated breast mass by mammography
title_full_unstemmed BRCA-2 (+) high-grade serous fallopian tube cancer diagnosed as an isolated breast mass by mammography
title_sort brca-2 (+) high-grade serous fallopian tube cancer diagnosed as an isolated breast mass by mammography
publisher Elsevier
series Gynecologic Oncology Reports
issn 2352-5789
publishDate 2021-02-01
description Ovarian cancer typically presents at advanced stage with intra-abdominal metastases. Rarely, ovarian cancer presents with distant metastases with little to no intra-abdominal disease burden. The patient was a BRCA-2 germline mutation carrier diagnosed with a Stage IVB high-grade carcinoma of the fallopian tube following discovery of a right axillary breast mass on screening mammography. Pre-operative imaging was without evidence of metastatic disease in the abdomen or pelvis. She underwent surgical staging followed by adjuvant chemotherapy and maintenance poly-ADP ribose polymerase (PARP) inhibition. She is without evidence of disease 24 months following her surgical staging procedure. An isolated oligo metastasis in the axilla is a rare presentation of ovarian carcinoma. Extra-abdominal metastases can present a diagnostic challenge in ovarian cancer necessitating thorough pathologic and radiologic work-up, particularly in the absence of intra-abdominal disease.
topic Ovarian cancer distant metastasis
BRCA-2
Breast mass
PARP inhibitor
url http://www.sciencedirect.com/science/article/pii/S2352578920301569
work_keys_str_mv AT janellensobecki brca2highgradeserousfallopiantubecancerdiagnosedasanisolatedbreastmassbymammography
AT kathrynadryer brca2highgradeserousfallopiantubecancerdiagnosedasanisolatedbreastmassbymammography
AT aparnammahajan brca2highgradeserousfallopiantubecancerdiagnosedasanisolatedbreastmassbymammography
AT ryanjspencer brca2highgradeserousfallopiantubecancerdiagnosedasanisolatedbreastmassbymammography
_version_ 1724274627702685696